이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Bariatric Surgery in Children. (BASIC)

2021년 8월 25일 업데이트: Maastricht University Medical Center

The BASIC Trial. Morbid Obesity in Children and Adolescents: a Prospective Randomised Trial of Conservative Treatment Versus Surgery

Rationale:

In the Western world overweight and obesity is an increasing problem both in adults and in children. In youth, it is associated with early death and a number of co-morbidities including metabolic and endocrine changes, increased inflammatory status, cardiovascular abnormalities, nonalcoholic fatty liver disease, and impaired quality of life.

The standard treatment for morbid obesity in children is by combined life style interventions. However, the medium and long term effects of dietetic interventions, behaviour therapy and medication is relatively poor. In adults bariatric surgery shows good results with up to 30% weight reduction in 3 years. The preliminary results in youth are similar, but surgery in this age group is relatively uncommon. In the Netherlands surgery in this age group is only allowed in clinical trials, until the benefits and risks have been established. (National Health Authorities)

Objective:

To determine if surgery gives a superior weight and body mass index (BMI) reduction than combined life style interventions in adolescents with morbid obesity and to assess its effect on obesity associated co-morbidity.

Study design:

Prospective randomised interventional study.

Study population:

Morbidly obese children, aged 14 - 16 years, with sex and age adjusted BMI >40 kg/m2 or >35 kg/m2 with co-morbidity.

Intervention:

Bariatric surgery by laparoscopic adjustable gastric band (LAGB) or combined life style interventions

Main study parameters/endpoints:

Primary endpoints: weight loss, loss of excess weight, loss of excess BMI. Secondary endpoints: Body composition, pubertal development, metabolic and endocrine changes, inflammatory status, cardiovascular abnormalities, non-alcoholic steatohepatitis, brain development, quality of life, and behaviour changes. The potential complications of surgery are monitored.

연구 개요

연구 유형

중재적

등록 (실제)

60

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Limburg
      • Maastricht, Limburg, 네덜란드, 6202ZA
        • Maastricht University Medical Center

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

14년 (어린이)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Aged 14 to 16
  • Age and sex adjusted BMI >40 kg/m2 or >35 kg/m2 with associated co-morbidity.

    * Associated co-morbidity includes: glucose intolerance, type 2 diabetes, hypertension, pseudotumor cerebri, acanthosis nigricans, obstructive sleep apnoea syndrome, depression, arthropathies, non-alcoholic steatohepatitis and dyslipidemia.

  • > 1 year multidisciplinary organized weight reducing attempts with less than 5% weight loss
  • Demonstrate decisional capacity

Exclusion Criteria:

  • Psychologically not suitable
  • Pre-menarche or bone age <15 years in boys
  • Obesity associated to other disorders such as hypothyroidism
  • Syndromal disorders such as Prader-Willi syndrome
  • Severe cardiorespiratory impairment (ASA class 3 or higher)
  • Insufficiently fluid in the Dutch language
  • Unwillingness to adhere to follow-up programmes

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: 대조군
Control group will receive standard therapy consisting of combined lifestyle interventions.
실험적: Laparoscopic adjustable gastric band
Laparoscopic gastric band placement. Combined lifestyle interventions will continue after surgery.
Control group will receive standard therapy consisting of combined lifestyle interventions.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Weight
기간: 6 months
Weight loss, excess weight loss and loss of excess BMI.
6 months
Weight
기간: 12 months
Weight loss, excess weight loss and loss of excess BMI.
12 months
Weight
기간: 24 months
Weight loss, excess weight loss and loss of excess BMI.
24 months
Weight
기간: 36 months
Weight loss, excess weight loss and loss of excess BMI.
36 months

2차 결과 측정

결과 측정
측정값 설명
기간
Body composition
기간: 12 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
12 months
Pubertal development
기간: 6 months
Follow-up of hormonal status and Tanner stages.
6 months
Metabolic and endocrine changes
기간: 6 months
6 months
Inflammatory status
기간: 6 months
Measurement of serum inflammatory markers.
6 months
Cardiovascular abnormalities
기간: 6 months
6 months
Non-alcoholic fatty liver disease
기간: 6 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
6 months
Quality of life changes
기간: 6 months
6 months
Behaviour changes
기간: 6 months
Measuring impulsivity and positive reward dominance with a computer task.
6 months
Operative complications
기간: up to 36 months
Early and late complications are being monitored
up to 36 months
Effects on sleep architecture
기간: 6 months
6 months
Brain development
기간: 6 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
6 months
Body composition
기간: 24 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
24 months
Body composition
기간: 36 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
36 months
Pubertal development
기간: 12 months
Follow-up of hormonal status and Tanner stages.
12 months
Pubertal development
기간: 24 months
Follow-up of hormonal status and Tanner stages.
24 months
Pubertal development
기간: 36 months
Follow-up of hormonal status and Tanner stages.
36 months
Metabolic and endocrine changes
기간: 12 months
12 months
Metabolic and endocrine changes
기간: 24 months
24 months
Metabolic and endocrine changes
기간: 36 months
36 months
Inflammatory status
기간: 12 months
Measurement of serum inflammatory markers.
12 months
Inflammatory status
기간: 24 months
Measurement of serum inflammatory markers.
24 months
Inflammatory status
기간: 36 months
Measurement of serum inflammatory markers.
36 months
Cardiovascular abnormalities
기간: 12 months
12 months
Cardiovascular abnormalities
기간: 24 months
24 months
Cardiovascular abnormalities
기간: 36 months
36 months
Non-alcoholic fatty liver disease
기간: 12 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
12 months
Non-alcoholic fatty liver disease
기간: 24 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
24 months
Non-alcoholic fatty liver disease
기간: 36 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
36 months
Quality of life changes
기간: 12 months
12 months
Quality of life changes
기간: 24 months
24 months
Quality of life changes
기간: 36 months
36 months
Effects on sleep architecture
기간: 12 months
12 months
Effects on sleep architecture
기간: 24 months
24 months
Effects on sleep architecture
기간: 36 months
36 months
Behaviour changes
기간: 12 months
Measuring impulsivity and positive reward dominance with a computer task.
12 months
Behaviour changes
기간: 24 months
Measuring impulsivity and positive reward dominance with a computer task.
24 months
Behaviour changes
기간: 36 months
Measuring impulsivity and positive reward dominance with a computer task.
36 months
Brain development
기간: 12 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
12 months
Brain development
기간: 24 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
24 months
Brain development
기간: 36 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
36 months
Physical activity
기간: 6 months
Assessment of physical activity using a questionnaire and an accelerometer.
6 months
Physical activity
기간: 12 months
Assessment of physical activity using a questionnaire and an accelerometer.
12 months
Physical activity
기간: 24
Assessment of physical activity using a questionnaire and an accelerometer.
24
Physical activity
기간: 36 months
Assessment of physical activity using a questionnaire and an accelerometer.
36 months
Behavior towards food
기간: 6 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
6 months
Behavior towards food
기간: 12 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
12 months
Behavior towards food
기간: 24 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
24 months
Behavior towards food
기간: 36 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
36 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: LWE van Heurn, Professor, Maastricht University Medical Center
  • 수석 연구원: Yvonne Roebroek, PhD Student, Maastricht University Medical Center
  • 수석 연구원: Givan F Paulus, PhD Student, Spaarne Gasthuis, Haarlem

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2011년 12월 1일

기본 완료 (예상)

2022년 12월 1일

연구 완료 (예상)

2022년 12월 1일

연구 등록 날짜

최초 제출

2010년 7월 22일

QC 기준을 충족하는 최초 제출

2010년 7월 29일

처음 게시됨 (추정)

2010년 7월 30일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2021년 8월 26일

QC 기준을 충족하는 마지막 업데이트 제출

2021년 8월 25일

마지막으로 확인됨

2021년 8월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • NL26279.068.09

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다